$VRDN 3 SEC Filings

Filed On	Filing
09 Apr 2025	Form 3: Ajer Jeffrey Robert, Director No securities owned
12 Mar 2025	Form 3: Tripuraneni Radhika, Chief Medical Officer
12 Mar 2025	Form 3: Cain Christopher W., Director No securities owned
14 Feb 2024	Form 3: Tousignant Jennifer, Chief Legal Officer No securities owned
12 Jan 2024	Form 3: Ciulla Thomas, Chief Medical Officer Holds 762 shares of Common Stock
01 Nov 2023	Form 3: Beetham Thomas W., Chief Operating Officer No securities owned
01 Nov 2023	Form 3: Mahoney Stephen F., Director No securities owned
25 Sep 2023	Form 3: Gheuens Sarah, Director No securities owned
19 Sep 2023	Form 3: Harmon Seth, See Remarks
07 Feb 2023	Form 3: Myers Scott Dunseth, Director No securities owned
24 Jun 2022	Form 3: Melvin Carrie, COO
04 Oct 2021	Form 3: Meisner Lara, General Counsel and Secretary
26 Aug 2021	Form 3: Frazier Life Sciences Public Fund, L.p., 10% owner and 2 others Holds 1,305,200 shares of Common Stock
27 Jul 2021	Form 3: Humer Kristian, CFO and CBO No securities owned
27 Jul 2021	Form 3: Humer Kristian, CFO and CBO No securities owned
15 Jul 2021	Form 3: Moses Jennifer K., Director No securities owned
21 Jan 2021	Form 3: Katz Barrett, Chief Medical Officer No securities owned
17 Dec 2020	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 3 others Holds 410,686 shares of Common Stock
20 Nov 2020	Form 3: Point72 Asset Management, L.p., 10% owner and 2 others Holds 426,162 shares of Common Stock
16 Nov 2020	Form 3: Logos Global Master Fund Lp, 10% owner Holds 6,000,000 shares of Common Stock

Comments